Grants Awarded



Click on any project title for a more detailed description of the project. For more information about any of these awards (e.g., PI contact information or associated publications), please use the corresponding project number to search for information at the NIH Reporter website. Consistent with NIH policy, abstracts are not available for projects receiving their first award within the past year, so descriptions provided below are from the NCI program director.

New awards will be posted as they are issued.

Year Award Typesort ascending Project # RFA # PI/Project Leader Institution Title Status
2015 R21 RFA-CA-14-003 HERR, AMY ELIZABETH UNIVERSITY OF CALIFORNIA BERKELEY MICROFLUIDIC WESTERN BLOTTING FOR TARGETED PROTEOMIC ANALYSIS OF SINGLE CIRCULATING TUMOR CELLS Complete
2018 R21 RFA-CA-17-010 ROYZEN, MAKSIM STATE UNIVERSITY OF NEW YORK AT ALBANY Development of Catch and Release Approach for Multi-Drug Local Delivery of Chemotherapies Active
2022 R21 CA21-003 LEE, HAKHO MASSACHUSETTS GENERAL HOSPITAL 3D Fourier Imaging System for High Throughput Analyses of Cancer Organoids Complete
2004 R21 PAR-01-106 JAY, DANIEL G. TUFTS UNIVERSITY BOSTON PROTEOME SIGNATURES AND TARGET VALIDATION IN LYMPHOMAS Complete
2007 R21 RFA-CA-07-015 WEIER, HEINZ-ULRICH G. UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB BAC-FISH ASSAYS FOR SENSITIVE KARYOTYPING OF CANCER CELLS Complete
2010 R21 RFA-CA-09-006 SIEGMUND, KIMBERLY D UNIVERSITY OF SOUTHERN CALIFORNIA APPLYING MOLECULAR PHYLOGENY TO PREDICT CLINICAL OUTCOMES IN CANCER Complete
2014 R21 RFA-CA-13-001 CHIU, DANIEL T UNIVERSITY OF WASHINGTON ULTRA-BRIGHT PROBES WITH ULTRA-NARROW EMISSION FOR MOLECULAR AND CELLULAR ANALYSI Complete
2017 R21 RFA-CA-16-001 KRON, STEPHEN J. UNIVERSITY OF CHICAGO Tag-ChIP-MS for analysis of chromatin-level regulation of DNA repair Complete
2021 R21 RFA-CA-20-017 XIAO, HAN RICE UNIVERSITY Development of Bone-Targeting Antibodies for Ewing Sarcoma Using Genetic Code Expansion Active
2001 R21 PAR-99-100 FRANK-KAMENETSKII, MAXIM D BOSTON UNIVERSITY STUDIES OF HEMATOLOGIC MALIGNANCIES BY PNA TECHNOLOGY Complete
2003 R21 PAR-01-106 ANGELETTI, RUTH HOGUE YESHIVA UNIVERSITY PROTEOMICS OF HEPATIC CARCINOGENESIS Complete
2009 R21 RFA-CA-08-007 TAINSKY, MICHAEL A WAYNE STATE UNIVERSITY SERUM BIOMARKERS FOR COLORECTAL CANCER DETECTION Complete
2013 R21 RFA-CA-13-001 VAN DAM, ROBERT MICHAEL UNIVERSITY OF CALIFORNIA LOS ANGELES COMPACT MICROFLUIDIC PET PROBE CONCENTRATOR FOR PRECLINICAL AND IN VITRO IMAGING Complete
2016 R21 RFA-CA-15-004 GARCIA, ANDRES J GEORGIA INSTITUTE OF TECHNOLOGY USHEAR TECHNOLOGY FOR CANCER CELL PURIFICAITON Complete
2006 R21 RFA-CA-06-002 WOODS, VIRGIL L UNIVERSITY OF CALIFORNIA SAN DIEGO DXMS-FACILITATED MEMBRANE PROTEIN CONSTRUCT DESIGN/CANCER Complete
2019 R21 RFA-CA-18-002 WU, YUN STATE UNIVERSITY OF NEW YORK AT BUFFALO Exosome-Protein-microRNA-OneStop (Exo-PROS) biosensor: a new liquid biopsy for cancer screening and early detection Active
2000 R21 PAR-98-067 BENNETT, SCOTT W SRA INTERNATIONAL, INC. INNOVATIVE ALGORITHMS FOR MICROARRAY ANALYSIS Complete
2002 R21 PAR-01-106 LEVENSON, VICTOR V NORTHWESTERN UNIVERSITY DNA METHYLATION IN PATIENTS WITH NON-HODGKIN'S LYMPHOMA Complete
2005 R21 RFA-CA-05-002 KRICHEVSKY, ANNA M. BRIGHAM AND WOMEN'S HOSPITAL TARGETING MIRNA IN BRAIN TUMORS. Complete
2008 R21 RFA-CA-07-033 LEVCHENKO, ANDRE JOHNS HOPKINS UNIVERSITY MICROFLUIDIC DEVICES FOR STUDYING CANCER SIGNAL TRANSDUCTION Complete
2011 R21 RFA-CA-10-003 MAKRIGIORGOS, G. MIKE DANA-FARBER CANCER INST HIGH-THROUGHPUT TECHNOLOGY THAT ENABLES SEQUENCING DEPTH FOR COLORECTAL CA Complete

Pages